Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2006 Mar;113(3):303-12.
doi: 10.1007/s00702-005-0323-3. Epub 2005 Jun 15.

Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm

P Roggenkämper  1 , W H Jost, K Bihari, G Comes, S Grafe; NT 201 Blepharospasm Study Team
Affiliations
Clinical Trial

Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm

P Roggenkämper et al. J Neural Transm (Vienna). 2006 Mar.

Abstract

NT 201 is a new development of Botulinum Toxin Type A free of complexing proteins. In this double-blind Phase III trial, we compared the efficacy and safety of NT 201 and BOTOX in patients suffering from blepharospasm. Of 304 enrolled patients, 300 patients received study medication (intent-to-treat population), and 256 patients completed the study as planned (per-protocol population). At baseline, patients received a single injection of NT 201 or BOTOX (<or=35 units per eye). No significant differences were found between NT 201 and BOTOX for all efficacy and safety variables three weeks after injection. Both the NT 201 and the BOTOX group showed a decrease in the Jankovic Rating Scale (JRS) sum score signifying an improvement in the symptoms of blepharospasm during this time period. These data show that NT 201* is an effective and safe treatment for patients suffering from blepharospasm.

PubMed Disclaimer

References

    1. Mov Disord. 2002;17 Suppl 3:S49-62 - PubMed
    1. Exp Neurol. 1997 Sep;147(1):96-102 - PubMed
    1. Jpn J Ophthalmol. 1995;39(4):424-31 - PubMed
    1. Ann Ophthalmol. 1984 Apr;16(4):371-6 - PubMed
    1. Acta Neurol Scand. 1996 Sep;94(3):172-6 - PubMed

Publication types

MeSH terms